Institutional members access full text with Ovid®

Share this article on:

In Reply

Raine-Bennett, Tina MD, MPH

doi: 10.1097/AOG.0b013e3182900166
Departments: Letters to the Editor

Women's Health Research Institute Kaiser Permanente Northern California Oakland, California

Financial Disclosure: Teva Pharmaceutical, which markets emergency contraception, several brands of oral contraceptives, and the copper IUD, provided research grant support to the University of California San Francisco for research on emergency contraception; that grant support was used by UCSF for salary support for Tina Raine-Bennett.

© 2013 by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.